Congenital Hypothyroidism

Role of the Egyptian Neonatal Screening Program in the Diagnosis of Congenital Hypothyroidism

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202606511369985

Enrollment

Registered

2026-06-15

Start date

2025-04-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases

Interventions

Re screening and Testing for positive cases of congenital hypothyroidism

estimating TSH in newborn babeis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All newborns born during the study period subjected to routine thyroid hormone testing under the national screening guidelines

Exclusion criteria

Exclusion criteria: Neonates diagnosed with other metabolic or genetic disorders, such as phenylketonuria (PKU) or galactosemia

Design outcomes

Primary

Measure	Time frame
Incidence rate of confirmed congenital hypothyroidism, Proportion of true-positive cases	—

Secondary

Measure	Time frame
Program performance metrics, Screening coverage rate (% of live births screened, False-negative rate, Clinical and demographic data at diagnosis:	—

Countries

Egypt

Contacts

Public ContactAmira Hamed

Professor of Pediatrics

Amira_hamed18@yaho.com+201026303947

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026